Health and Healthcare

Inovio Pharmaceuticals : INO

All Inovio Pharmaceuticals Articles

52 Articles

Chris Lange | Apr 30, 2015 at 10:25 AM EDT

How the Inovio Secondary Crushed Its Shareholders

A lot of times when companies have secondary offerings the price takes a slight dip to accommodate the dilution and…

Lee Jackson | Aug 16, 2014 at 9:10 AM EDT

Insider Buying This Week Dominated by Pharma and Yield Chasers

ThinkstockInvestors love to see insiders at high corporate levels purchasing their own companies’ stock. That is particularly true if the…

Jon C. Ogg | Mar 1, 2014 at 10:39 AM EST

Top Biotech Stocks Under $5 With Huge Potential Upside

ThinkstockWith the top stocks in the market exploding in price due to the recent rally, we wanted to scan across…

Paul Ausick | Aug 5, 2013 at 4:05 PM EDT

Closing Bell for Monday on Wall Street: Markets Open Lower, Mixed at Closing

August 5, 2013: U.S. equity markets opened lower this morning, lacking any major news of interest from around the globe.…

Jon C. Ogg | Mar 26, 2010 at 3:31 PM EDT

BioHealth Business Daily (ABIO, GENZ, SOMX, CRXX, VVUS, INO)

Today was a crazy day for the markets, and as you’d expect there were many movers in the drug and…

Douglas A. McIntyre | Jul 29, 2009 at 11:32 AM EDT

Swine Flu Research Causes 165% Surge In Inovio (INO)

As first reported at our affiliate site BioHealth Investor: Inovio Biomedical Corporation (NYSE Amex: INO) has been higher by over…

Douglas A. McIntyre | Jun 19, 2007 at 7:11 AM EDT

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement…

1 2 3 4

Inovio Pharmaceuticals : INO

All Inovio Pharmaceuticals Articles

How the Inovio Secondary Crushed Its Shareholders

Insider Buying This Week Dominated by Pharma and Yield Chasers

Top Biotech Stocks Under $5 With Huge Potential Upside

Closing Bell for Monday on Wall Street: Markets Open Lower, Mixed at Closing

BioHealth Business Daily (ABIO, GENZ, SOMX, CRXX, VVUS, INO)

Swine Flu Research Causes 165% Surge In Inovio (INO)

Pre-Market Stock News (June 19, 2007)

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Inovio Pharmaceuticals : INO

All Inovio Pharmaceuticals Articles

How the Inovio Secondary Crushed Its Shareholders

Insider Buying This Week Dominated by Pharma and Yield Chasers

Top Biotech Stocks Under $5 With Huge Potential Upside

Closing Bell for Monday on Wall Street: Markets Open Lower, Mixed at Closing

BioHealth Business Daily (ABIO, GENZ, SOMX, CRXX, VVUS, INO)

Swine Flu Research Causes 165% Surge In Inovio (INO)

Pre-Market Stock News (June 19, 2007)

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do